Stock Events

Stock Events

Cullinan Therapeutics (CGEM) Q1 2026 Earnings

10MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-1.07

-0.96

-0.85

-0.74

Details

Expected EPS

-0.809401

Actual EPS

-0.77

Surprise EPS

0.04

Surprise Percent

+4.87%

Description

Cullinan Therapeutics (CGEM) has reported earnings of -0.77 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.